日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data

促性腺激素释放激素激动剂在化疗期间用于保护绝经前早期乳腺癌患者的卵巢功能和生育能力：一项基于个体患者数据的系统评价和荟萃分析

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2018.78.0858
Lambertini, Matteo; Moore, Halle C F; Leonard, Robert C F; Loibl, Sibylle; Munster, Pamela; Bruzzone, Marco; Boni, Luca; Unger, Joseph M; Anderson, Richard A; Mehta, Keyur; Minton, Susan; Poggio, Francesca; Albain, Kathy S; Adamson, Douglas J A; Gerber, Bernd; Cripps, Amy; Bertelli, Gianfilippo; Seiler, Sabine; Ceppi, Marcello; Partridge, Ann H; Del Mastro, Lucia
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2018
文献求助 收藏

Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer

利用进化原理延长乳腺癌临床前模型中的肿瘤控制时间

期刊:Science Translational Medicine
影响因子:14.6
doi:10.1126/scitranslmed.aad7842
Enriquez-Navas, Pedro M; Kam, Yoonseok; Das, Tuhin; Hassan, Sabrina; Silva, Ariosto; Foroutan, Parastou; Ruiz, Epifanio; Martinez, Gary; Minton, Susan; Gillies, Robert J; Gatenby, Robert A
肿瘤
肿瘤免疫
乳腺癌
发表日期：2016
文献求助 收藏

A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors

一项针对晚期或难治性实体瘤患者的 I 期研究，评估了口服 Aurora 激酶抑制剂 MK-5108 作为单药疗法以及与多西他赛联合疗法的疗效。

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-015-0306-7
Amin, Manik; Minton, Susan E; LoRusso, Patricia M; Krishnamurthi, Smitha S; Pickett, Cheryl A; Lunceford, Jared; Hille, Darcy; Mauro, David; Stein, Mark N; Wang-Gillam, Andrea; Trull, Lauren; Lockhart, A Craig
信号转导
发表日期：2016
文献求助 收藏

A phase I study of indoximod in patients with advanced malignancies

一项针对晚期恶性肿瘤患者的吲哚莫德 I 期研究

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.8216
Soliman, Hatem H; Minton, Susan E; Han, Hyo Sook; Ismail-Khan, Roohi; Neuger, Anthony; Khambati, Fatema; Noyes, David; Lush, Richard; Chiappori, Alberto A; Roberts, John D; Link, Charles; Vahanian, Nicholas N; Mautino, Mario; Streicher, Howard; Sullivan, Daniel M; Antonia, Scott J
肿瘤
肿瘤免疫
发表日期：2016
文献求助 收藏

Sweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with "ersatzdroges"

徒劳无功：用“替代药物”抑制多药耐药癌细胞的增殖

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.29158
Kam, Yoonseok; Das, Tuhin; Tian, Haibin; Foroutan, Parastou; Ruiz, Epifanio; Martinez, Gary; Minton, Susan; Gillies, Robert J; Gatenby, Robert A
细胞生物学
肿瘤
肿瘤免疫
发表日期：2015
文献求助 收藏

Pilot study of Iyengar yoga for management of aromatase inhibitor-associated arthralgia in women with breast cancer

艾扬格瑜伽治疗乳腺癌女性芳香化酶抑制剂相关关节痛的初步研究

期刊:Psycho-Oncology
影响因子:3.5
doi:10.1002/pon.3756
Jacobsen, Paul B; Muchnick, Suzie; Marcus, Susan; Amheiser, Patricia; Reiersen, Pamela; Gonzalez, Brian; Gomez, Maria; Jim, Heather S L; Thompson, Lora M A; Minton, Susan; Bower, Julienne
肿瘤免疫
肿瘤
乳腺癌
发表日期：2015
文献求助 收藏

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors

口服 AKT 抑制剂 MK-2206 联合卡铂/紫杉醇、多西他赛或厄洛替尼治疗晚期实体瘤患者的 1 期临床试验

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/1756-8722-7-1
Molife, L Rhoda; Yan, Li; Vitfell-Rasmussen, Joanna; Zernhelt, Adriane M; Sullivan, Daniel M; Cassier, Philippe A; Chen, Eric; Biondo, Andrea; Tetteh, Ernestina; Siu, Lillian L; Patnaik, Amita; Papadopoulos, Kyriakos P; de Bono, Johann S; Tolcher, Anthony W; Minton, Susan
AKT
发表日期：2014
文献求助 收藏

Factors associated with breast cancer worry 3 years after completion of adjuvant treatment

辅助治疗结束后3年与乳腺癌担忧相关的因素

期刊:Psycho-Oncology
影响因子:3.5
doi:10.1002/pon.3066
Phillips, Kristin M; McGinty, Heather L; Gonzalez, Brian D; Jim, Heather S L; Small, Brent J; Minton, Susan; Andrykowski, Michael A; Jacobsen, Paul B
肿瘤
肿瘤免疫
乳腺癌
发表日期：2013
文献求助 收藏

Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer

一项随机试验，使用促性腺激素释放激素激动剂曲普瑞林在乳腺癌（新）辅助化疗期间保护卵巢功能

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2011.34.6890
Munster, Pamela N; Moore, Amy P; Ismail-Khan, Roohi; Cox, Charles E; Lacevic, Mensura; Gross-King, Margaret; Xu, Ping; Carter, W Bradford; Minton, Susan E
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2012
文献求助 收藏

History of major depressive disorder prospectively predicts worse quality of life in women with breast cancer

既往有重度抑郁症病史预示着乳腺癌女性患者的生活质量较差。

期刊:Annals of Behavioral Medicine
影响因子:3.3
doi:10.1007/s12160-011-9333-6
Jim, Heather S L; Small, Brent J; Minton, Susan; Andrykowski, Michael; Jacobsen, Paul B
肿瘤
肿瘤免疫
神经科学
乳腺癌
抑郁症
发表日期：2012
文献求助 收藏